Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00043745 · ClinicalTrials.gov registry record · Phase 2
Bone Response to Soy Isoflavones in Women
A Phase 2 study, sponsored by Iowa State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 224
- Enrollment target
NCT00043745 is a Phase 2 study that has completed, run by Iowa State University. The registered enrollment target is 224 participants.
The verdict
NCT00043745, a Phase 2 study, has completed, sponsored by Iowa State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 224 participants
- Enrollment target
Study Summary
This study will provide valuable data on whether soy isoflavones impact bone loss in postmenopausal women. The study will help clarify potential mechanisms and contribute to our understanding of isoflavones as an alternative to traditional hormone therapy.
Interventions
- DIETARY_SUPPLEMENT Soy isoflavones
- DIETARY_SUPPLEMENT Extract tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2003-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00043745
The ClinicalTrials.gov registry entry for NCT00043745 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iowa State University, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Soy isoflavones is the first listed.
NCT00043745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00043745 about?
NCT00043745 is a clinical study titled "Bone Response to Soy Isoflavones in Women". This study will provide valuable data on whether soy isoflavones impact bone loss in postmenopausal women. The study will help clarify potential mechanisms and contribute to our understanding of isoflavones as an alternative to traditional hormone therapy.
What is the current status of trial NCT00043745?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 224 participants. The study started on 2003-03.
What interventions are being tested in trial NCT00043745?
The interventions under investigation include: Soy isoflavones (DIETARY_SUPPLEMENT), Extract tablets (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00043745?
This trial is sponsored by Iowa State University, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.